Valuation: Cutia Therapeutics

Market Cap 608M 709M 90.38M 77.42M 72.44M 66.31M 124M 8.65B 126M 856M 334M 4.34B 339M 332M 14.37B P/E 2026 *
-3.65x
P/E 2027 * 12.8x
Enterprise Value 676M 789M 101M 86.17M 80.63M 73.81M 139M 9.63B 140M 953M 371M 4.84B 378M 370M 15.99B EV / Sales 2026 *
1.05x
EV / Sales 2027 * 0.51x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 day-10.14%
1 week-12.56%
Current month-16.67%
1 month-24.12%
3 months-53.12%
6 months-60.45%
Current year-57.05%
1 week 1.9
Extreme 1.9
2.3
1 month 1.9
Extreme 1.9
2.68
Current year 1.9
Extreme 1.9
5.51
1 year 1.9
Extreme 1.9
12
3 years 1.9
Extreme 1.9
31
5 years 1.9
Extreme 1.9
32.6
10 years 1.9
Extreme 1.9
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Director/Board Member 48 2020-05-11
Chairman 63 2019-08-22
Director/Board Member 36 2022-11-14
Date Insider Type Main position Quantity % Market Cap.
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-10.14%-12.56%-79.60%-92.14% 90.38M
+0.88%+6.38%+76.40%+126.87% 1,119B
+1.07%+3.80%+50.73%+64.25% 651B
+1.20%+6.21%+25.81%+80.15% 468B
+1.02%+5.77%+43.63%+43.06% 374B
+0.85%+4.07%+24.97%+41.00% 302B
+1.26%+6.81%+2.27%+13.65% 259B
+1.88%+5.81%+49.57%+70.71% 238B
+1.59%+2.09%-17.33%-53.85% 208B
+1.87%+5.61%+27.32%+89.67% 181B
Average +0.15%+3.40%+20.38%+38.34% 379.99B
Weighted average by Cap. +1.14%+5.40%+44.26%+72.42%

Financials

2026 *2027 *
Net sales 646M 753M 96.08M 82.3M 77.01M 70.49M 132M 9.19B 134M 910M 355M 4.62B 361M 353M 15.27B 1.18B 1.38B 176M 150M 141M 129M 242M 16.79B 245M 1.66B 648M 8.44B 659M 645M 27.9B
Net income -146M -170M -21.68M -18.57M -17.38M -15.9M -29.85M -2.07B -30.24M -205M -80.05M -1.04B -81.4M -79.63M -3.45B 44.25M 51.6M 6.58M 5.64M 5.28M 4.83M 9.06M 630M 9.18M 62.33M 24.31M 316M 24.72M 24.18M 1.05B
Net Debt 68.7M 80.12M 10.22M 8.75M 8.19M 7.5M 14.07M 978M 14.26M 96.77M 37.74M 491M 38.37M 37.54M 1.62B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
-
Date Price Change Volume
26-08-21 HK$1.950 -10.14% 633,400
26-08-20 HK$2.170 +0.46% 91,000
26-08-19 HK$2.160 -1.37% 116,000
26-08-18 HK$2.190 -1.79% 58,800
26-08-17 HK$2.230 0.00% 62,800
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.672CNY
Average target price
9.801CNY
Spread / Average Target
+486.18%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock